Harnal D


Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 19.8%
Prostate Cancer 16.4%
Drug Use For Unknown Indication 10.3%
Hyperlipidaemia 9.5%
Hyperuricaemia 8.6%
Benign Prostatic Hyperplasia 7.8%
Gastritis 6.9%
Cerebrovascular Disorder 5.2%
Gastritis Prophylaxis 4.3%
Dementia Alzheimer's Type 2.6%
Prostatism 2.6%
Cerebral Infarction 1.7%
Gastric Ulcer 1.7%
Raynaud's Phenomenon 1.7%
Intervertebral Disc Protrusion 0.9%
Drug Eruption 16.7%
Melaena 16.7%
Intervertebral Disc Protrusion 12.5%
Hypoglycaemia 8.3%
Spinal Compression Fracture 8.3%
Ventricular Extrasystoles 8.3%
Vomiting 8.3%
Wrong Drug Administered 8.3%
Diabetes Mellitus Inadequate Control 4.2%
Pneumonia 4.2%
Supraventricular Extrasystoles 4.2%
Concomitant
Benign Prostatic Hyperplasia 16.7%
Prophylaxis 11.2%
Hypertension 8.4%
Product Used For Unknown Indication 6.7%
Prostate Cancer Stage Iv 6.5%
Constipation 5.3%
Hyperuricaemia 5.2%
Hyperlipidaemia 5.1%
Cerebral Infarction 4.3%
Diabetes Mellitus 4.0%
Prostate Cancer 3.3%
Multiple Myeloma 3.2%
Atrial Fibrillation 3.1%
Cancer Pain 3.0%
Colorectal Cancer 2.8%
Insomnia 2.7%
Gastritis 2.1%
Prostate Cancer Stage Ii 2.1%
Renal Cell Carcinoma Stage Iv 2.1%
Drug Use For Unknown Indication 2.1%
Interstitial Lung Disease 9.8%
Pneumonia 9.0%
Tracheal Haemorrhage 6.6%
Urinary Retention 6.6%
Palmar-plantar Erythrodysaesthesia Syndrome 5.7%
White Blood Cell Count Decreased 5.7%
Platelet Count Decreased 4.9%
Prostate Cancer 4.9%
Renal Impairment 4.9%
Anaemia 4.1%
Death 4.1%
Hemiplegia 4.1%
Hepatic Function Abnormal 4.1%
Rash 4.1%
Sepsis 4.1%
Upper Respiratory Tract Inflammation 4.1%
Gastric Ulcer Haemorrhage 3.3%
Liver Disorder 3.3%
Pulmonary Alveolar Haemorrhage 3.3%
Pyrexia 3.3%

Drug Data